Search by Drug Name or NDC
NDC 00004-0357-30 Pegasys 180 ug/.5mL Details
Pegasys 180 ug/.5mL
Pegasys is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Genentech, Inc.. The primary component is PEGINTERFERON ALFA-2A.
MedlinePlus Drug Summary
Peginterferon alfa-2a is used alone or in combination with other medications to treat chronic (long-term) hepatitis C infection (swelling of the liver caused by a virus) in people who show signs of liver damage. Peginterferon alfa-2a is also used to treat chronic hepatitis B infection (swelling of the liver caused by a virus) in people who show signs of liver damage. Peginterferon alfa-2a is in a class of medications called interferons. Peginterferon is a combination of interferon and polyethylene glycol, which helps the interferon stay active in your body for a longer period of time. Peginterferon works by decreasing the amount of hepatitis C virus (HCV) or hepatitis B virus (HBV) in the body. Peginterferon alfa-2a may not cure hepatitis C or hepatitis B or prevent you from developing complications of hepatitis C or hepatitis B such as cirrhosis (scarring) of the liver, liver failure, or liver cancer. Peginterferon alfa-2a may not prevent the spread of hepatitis C or hepatitis B to other people.
Related Packages: 00004-0357-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Peginterferon Alfa-2a Injection
Product Information
| NDC | 00004-0357 |
|---|---|
| Product ID | 0004-0357_cc1e24aa-6242-4429-bfeb-c92907641f3e |
| Associated GPIs | 1235306005E540 |
| GCN Sequence Number | 050736 |
| GCN Sequence Number Description | peginterferon alfa-2a SYRINGE 180MCG/0.5 SUBCUT |
| HIC3 | W5G |
| HIC3 Description | HEPATITIS C TREATMENT AGENTS |
| GCN | 17887 |
| HICL Sequence Number | 024035 |
| HICL Sequence Number Description | PEGINTERFERON ALFA-2A |
| Brand/Generic | Brand |
| Proprietary Name | Pegasys |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | peginterferon alfa-2a |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 180 |
| Active Ingredient Units | ug/.5mL |
| Substance Name | PEGINTERFERON ALFA-2A |
| Labeler Name | Genentech, Inc. |
| Pharmaceutical Class | Interferon alpha [EPC], Interferon-alpha [CS] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA103964 |
| Listing Certified Through | n/a |
Package
NDC 00004-0357-30 (00004035730)
| NDC Package Code | 0004-0357-30 |
|---|---|
| Billing NDC | 00004035730 |
| Package | 1 PACKET in 1 BOX (0004-0357-30) / 4 SYRINGE, GLASS in 1 PACKET / .5 mL in 1 SYRINGE, GLASS |
| Marketing Start Date | 2011-03-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |